Cardiovascular Disease, Comorbidities, and Late Adult in Indonesia:  a Cross-Sectional Population-Based National Survey

Tri Wahyuni; Dwi Rahmah Fitriani; Joanggi Wiriatarina Harianto; Ritanti Ritanti

doi:10.26714/mki.5.3.2022.208-215

Cardiovascular Disease, Comorbidities, and Late Adult in Indonesia: a Cross-Sectional Population-Based National Survey

Tri Wahyuni^(1*), Dwi Rahmah Fitriani⁽²⁾, Joanggi Wiriatarina Harianto⁽³⁾, Ritanti Ritanti⁽⁴⁾

(1) Faculty of Nursing, Universitas Muhammadiyah Kalimantan Timur
(2) Faculty of Nursing, Universitas Muhammadiyah Kalimantan Timur
(3) Faculty of Nursing, Universitas Muhammadiyah Kalimantan Timur
(4) Faculty of Health Science, Universitas Universitas Pembangunan Nasional Veteran Jakarta
(*) Corresponding Author

Abstract

The aging population is predominantly predisposed to heart illness. Age is an autonomous danger factor for cardiovascular disease (CVD) in adults, but this risk is exacerbated by additional factors, including comorbidities. This study aimed to determine the prevalence of cardiovascular disease and the association between comorbidities and cardiovascular disease among late adults in Indonesia. This cross-sectional research utilizes the data national population survey from the Indonesia Family Life Survey wave 5 (2015). Multistage stratified random sampling was utilized to choose the respondents to respond to a structured questionnaire interview, laboratory test, and anthropometric measurements. Multivariable logistic regression was utilized to determine the association. The result was respondents’ age mean was 48.31 (±5.83) years. CVD prevalence was 2.36% (95% CI: 2.07 – 2.70). The final model of a multivariable analysis using multiple logistic regression indicated that CKD (adj. OR = 3.04, 95%CI 1.76 – 5.24, p = <0.001), hyper cholesterol (adj. OR = 2.77, 95%CI 1.20 – 3.90, p = <0.001), stroke (adj. OR = 2.66, 95%CI 1.36 – 5.24, p = 0.004), having hypertension (adj. OR = 1.83, 95% 1.35 – 2.49, p = <0.001), high blood sugar (adj. OR = 1.82, 95%CI 1.17 – 2.86, p = 0.008), were significantly associated with CVD among late adults. Other significant covariate was age (adj. OR = 1.04, 95%CI 1.01 – 1.06, p = 0.003) and sex (adj. OR = 1.43, 95%CI 1.07 – 1.92, p = 0.015). The conclusion was comorbidities, age, and sex was associated with CVD among late adults in Indonesia.

Keywords

Cardiovascular disease; CVD; Comorbidities; Late adult

Full Text:

PDF

References

Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, et al. Cardiovascular Risks Associated with Gender and Aging. J Cardiovasc Dev Dis 2019;6:19. https://doi.org/10.3390/jcdd6020019.

Maharani A, Sujarwoto, Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PLoS One 2019;14:1–13. https://doi.org/10.1371/journal.pone.0215219.

WHO. Cardiovascular diseases ( CVDs ). Fact Sheet WHO 2017.

MoH-RI. Situasi Kesehatan Jantung. Infodatin - Pus Data Dan Inf Kementeri Kesehat RI 2018.

WHO. Cardiovascular Diseases. Fact Sheet WHO 2019.

Adisasmito W, Amir V, Atin A, Megraini A, Kusuma D. Geographic and socioeconomic disparity in cardiovascular risk factors in Indonesia: analysis of the Basic Health Research 2018. BMC Public Health 2020;20:1004. https://doi.org/10.1186/s12889-020-09099-1.

Kementerian Kesehatan RI. Laporan Nasional RISKESDAS 2018. 2019.

Hussain MA, Mamun A Al, Peters SAE, Woodward M, Huxley RR. The burden of cardiovascular disease attributable to major modifiable risk factors in Indonesia. J Epidemiol 2016;26:515–21. https://doi.org/10.2188/jea.JE20150178.

Uli RE, Satyana RPU, Zomer E, Magliano D, Liew D, Ademi Z. Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling. BMJ Open 2020;10:1–9. https://doi.org/10.1136/bmjopen-2020-039221.

Strauss J, Witoelar F, Sikoki B. The Fifth Wave of the Indonesia Family Life Survey: Overview and Field Report: Volume 1. Fifth Wave Indones Fam Life Surv Overv F Rep Vol 1 2016. https://doi.org/10.7249/wr1143.1.

Pengpid S, Peltzer K. The Prevalence of Underweight, Overweight/Obesity and Their Related Lifestyle Factors in Indonesia, 2014–15. AIMS Public Heal 2017;4:633–49. https://doi.org/10.3934/publichealth.2017.6.633.

WHO. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Miner Nutr Inf Syst World Heal Organ 2013:1–6. https://doi.org/2011.

Hosmer D, Lemeshow S. Applied logistic regression, 2nd Edition edn. New York: Willey 2000.

Peltzer K, Pengpid S. Prevalence , risk awareness and health beliefs of behavioural risk factors for cardiovascular disease among university students in nine ASEAN countries. BMC Public Health 2018. https://doi.org/10.1186/s12889-018-5142-1.

Tomey MI, Winston JA. Cardiovascular pathophysiology in chronic kidney disease: Opportunities to transition from disease to health. Ann Glob Heal 2014;80:69–76. https://doi.org/10.1016/j.aogh.2013.12.007.

Drüeke TB, Floege J. Cardiovascular complications of chronic kidney disease: pioneering studies. Kidney Int 2020;98:522–6. https://doi.org/10.1016/j.kint.2020.07.001.

Liu M, Li XC, Lu L, Cao Y, Sun RR, Chen S ZP. Cardiovascular disease and its relationship with chronic kidney. Eur Rev Med Pharmacol Sci 2014 Oct;18(19)2918-26 2014;18.

AKF. Heart disease & chronic kidney disease ( CKD ). Am Kidney Fund 2019;Fact Sheet.

Gantagad T, Sindhu S, Viwatwongkasem C, Utriyaprasit K. Factors Predicting the Progression of Chronic Kidney Disease in the Northern Region of Thailand. Suranaree J Sci Technol 2021;28:1–9.

Jeong SM, Choi S, Kim K, Kim SM, Lee G. Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults. J Am Heart Assoc 2018;7. https://doi.org/10.1161/JAHA.118.008819.

Doehner W, Mazighi M, Hofmann BM, Lautsch D, Hindricks G, Bohula EA, et al. Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table. Eur J Prev Cardiol 2020;27:682–92. https://doi.org/10.1177/2047487319873460.

Sposato LA, Hilz MJ, Aspberg S, Murthy SB, Bahit MC, Hsieh CY, et al. Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:2768–85. https://doi.org/10.1016/j.jacc.2020.10.009.

Wang JC, Chien WC, Chu P, Chung CH, Lin CY, Tsai SH. The association between heat stroke and subsequent cardiovascular diseases. PLoS One 2019;14:1–11. https://doi.org/10.1371/journal.pone.0211386.

CHD-Indonesia. Penyakit Jantung Koroner. Smart Patient 2016:1–8.

Wu C, Hu H, Chou Y, Huang N, Chou Y. High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults. Med (Baltimore) 2015 Nov; 94(47) E2160 2015;94. https://doi.org/10.1097/MD.0000000000002160.

NIH. Diabetes, Heart Disease, and Stroke 2018:National Institute of Diabetes and Digestive and K.

Matheus ASDM, Tannus LRM, Cobas RA, Palma CCS, Negrato CA, Gomes MDB. Impact of diabetes on cardiovascular disease: An update. Int J Hypertens 2013;2013. https://doi.org/10.1155/2013/653789.

Schmidt AM. Diabetes Mellitus and Cardiovascular Disease. Arterioscler Thromb Vasc Biol 2019;39:558–68. https://doi.org/10.1161/ATVBAHA.119.310961.

Rahman S, Majumder MAA, Kabir R, Haque M, Gupta S, Arafat SMY, et al. Cardiovascular Disease and Diabetes: Two Sides of the Same Coin! Recent Trends Cardiovasc. Risks, 2017. https://doi.org/10.5772/intechopen.69038.

Dhingra R, Vasan RS. Age As a Cardiovascular Risk Factor. Med Clin North Am 2012;96:87–91. https://doi.org/10.1016/j.mcna.2011.11.003.

Gong FF, Coller JM, McGrady M, Boffa U, Shiel L, Liew D, et al. Age-related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk. ESC Hear Fail 2020;7:1344–61. https://doi.org/10.1002/ehf2.12687.

Tiffe T, Wagner M, Rücker V, Morbach C, Gelbrich G, Störk S, et al. Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study. BMC Cardiovasc Disord 2017;17:1–12. https://doi.org/10.1186/s12872-017-0708-x.

Ventura-Clapier R, Piquereau J, Garnier A, Mericskay M, Lemaire C, Crozatier B. Gender issues in cardiovascular diseases. Focus on energy metabolism. Biochim Biophys Acta - Mol Basis Dis 2020;1866:165722. https://doi.org/10.1016/j.bbadis.2020.165722.

Kalibala J, Pechère-Bertschi A, Desmeules J. Gender Differences in Cardiovascular Pharmacotherapy—the Example of Hypertension: A Mini Review. Front Pharmacol 2020;11:1–8. https://doi.org/10.3389/fphar.2020.00564.

Deng B, Guo M. Risk Factors and Intervention Status of Cardiovascular Disease in Elderly Patients with Coronary Heart Disease. Health (Irvine Calif) 2020;12:857–65. https://doi.org/10.4236/health.2020.127063.